These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Lentigo maligna and malignant melanoma. Jackson R; Williamson GS; Beattie WG Can Med Assoc J; 1966 Oct; 95(17):846-51. PubMed ID: 5922502 [TBL] [Abstract][Full Text] [Related]
25. Melanocytic lesions of the eyelid skin. Naidoff MA; Bernardino VB; Clark WH Am J Ophthalmol; 1976 Sep; 82(3):371-82. PubMed ID: 961789 [TBL] [Abstract][Full Text] [Related]
26. Histochemical findings in different types of malignant melanoma: biological and clinical significance. Paul E Arch Dermatol Res (1975); 1975 Dec; 254(2):159-74. PubMed ID: 814858 [TBL] [Abstract][Full Text] [Related]
27. Following lentigo maligna may not prevent the development of life-threatening melanoma. Kelly JW Arch Dermatol; 1992 May; 128(5):657-60. PubMed ID: 1575529 [TBL] [Abstract][Full Text] [Related]
28. In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. Steiner A; Pehamberger H; Wolff K J Am Acad Dermatol; 1987 Oct; 17(4):584-91. PubMed ID: 3668003 [TBL] [Abstract][Full Text] [Related]
29. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases]. Ren M; Kong YY; Shen XX; Cai X; Kong JC Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732 [No Abstract] [Full Text] [Related]
30. In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna. Langley RG; Burton E; Walsh N; Propperova I; Murray SJ J Am Acad Dermatol; 2006 Jul; 55(1):88-97. PubMed ID: 16781299 [TBL] [Abstract][Full Text] [Related]
31. [Dubreuilh melanoma: and epidemiologic and prognostic study]. Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003 [TBL] [Abstract][Full Text] [Related]
32. Unstable solar lentigo: A defined separate entity. Byrom L; Barksdale S; Weedon D; Muir J Australas J Dermatol; 2016 Aug; 57(3):229-34. PubMed ID: 26832231 [TBL] [Abstract][Full Text] [Related]
33. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma. Harwood AR J Am Acad Dermatol; 1982 Mar; 6(3):310-6. PubMed ID: 7068960 [TBL] [Abstract][Full Text] [Related]
34. Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid. McLean DI; Peter KK Br J Dermatol; 1986 Jun; 114(6):685-9. PubMed ID: 3718862 [TBL] [Abstract][Full Text] [Related]
35. Lentigo maligna: review of salient characteristics and management. Kallini JR; Jain SK; Khachemoune A Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181 [TBL] [Abstract][Full Text] [Related]
36. Extrafacial Lentigo Maligna: A Report on 14 Cases and a Review of the Literature. Martínez-Leboráns L; Garcías-Ladaria J; Oliver-Martínez V; Alegre de Miquel V Actas Dermosifiliogr; 2016 Oct; 107(8):e57-63. PubMed ID: 27180003 [TBL] [Abstract][Full Text] [Related]
37. Lentigo maligna and lentigo maligna melanoma in young adults. Durnick A; Stolz W; Landthaler M; Vogt T Dermatol Surg; 2004 May; 30(5):813-6. PubMed ID: 15099332 [TBL] [Abstract][Full Text] [Related]
38. Malignant melanomas of the conjunctiva. Bernardino VB; Naidoff MA; Clark WH Am J Ophthalmol; 1976 Sep; 82(3):383-94. PubMed ID: 961790 [TBL] [Abstract][Full Text] [Related]
39. Melanoma: criteria for histological diagnosis and its reporting. Metcalf JS Semin Oncol; 1996 Dec; 23(6):688-92. PubMed ID: 8970588 [TBL] [Abstract][Full Text] [Related]
40. Senile lentigo--cosmetic or medical issue of the elderly population. Situm M; Bulat V; Buljan M; Puljiz Z; Situm V; Bolanca Z Coll Antropol; 2010 Apr; 34 Suppl 2():85-8. PubMed ID: 21302707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]